From: Proceedings of the 27th European Paediatric Rheumatology Congress (PReS 2021)
Test | Number of patients (%) |
---|---|
Positive ANA > 1:80 in IFI | 172 (97.2%) |
Positive anti-dsDNA antibodies | 133 (75.1%) |
Positive anti-Sm antibodies | 16 (9%) |
Lupus anticoagulant | 29 (16.4%) |
Leukopenia (<4,000 leukocytes/mm3) | 62 (35%) |
Thrombocytopenia (<100,000 platelets/mm3) | 35 (19.8%) |
Anemia (Hb < 12 g/dL) | 115 (65%) |
Raised ESR | 132 (74.6%) |
Raised CRP | 21 (11.9%) |